No abstract available
Keywords:
adverse events; biologics; clinical efficacy; dupilumab; prurigo nodularis; real-world.
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Eosinophils
-
Humans
-
Neurodermatitis*
-
Prospective Studies
-
Prurigo* / drug therapy
-
Pruritus
Substances
-
dupilumab
-
Antibodies, Monoclonal, Humanized